Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 June 2005 : Case report  

The additive effects of carnitine and ascorbic acid on distally burned dorsal skin flap in rats

Emrah Arslan, Yavuz Basterzi, Alper Aksoy, Christopher Majka, Sakir Unal, Alper Sari, Ferit Demirkan

Med Sci Monit 2005; 11(6): BR176-180 :: ID: 16488

Abstract

Summary
Background: The purpose of this study was to determine the effects of combined use of L-carnitine and vitamin C on partially burned skin fl ap in an experimental rat model.
Material/Methods: In the rat dorsal skin, a 10×3 cm fl ap was marked. The most distal 3×3 cm part was burned to full thickness. Twenty-four rats were randomized into four groups with 6 animals in each. Group 1 was simply followed up. Group 2 was given 0.5 mg/kg vitamin C per day for 7 days, group 3 100 mg/kg carnitine per day for 7 days, and group 4 both carnitine and vitamin C. On the eighth postoperative
day, the animals were sacrifi ced and examined. The surviving and necrotic areas were determined by macroscopic examination and measured with a planimeter.
Results: The areas of fl ap necrosis were measured. The median surviving areas and areas of fl ap necrosis, respectively, of the groups were: group 1, 16.0 cm2 and 14.0 cm2; group 2, 18.25 cm2 and 11.75 cm2; group 3, 20.0 cm2 and 10 cm2; and group 4, 23.75 cm2 and 6.25 cm2. The surviving areas of the groups were found to be signifi cantly different (p=0.000).
Conclusions: The risk of ischemia-induced necrosis in fl ap attempts made in damaged tissues may be reduced by the combination of two promising agents, L-carnitine and vitamin C. L-carnitine appears to be
the major contributing factor that reduces necrosis, and vitamin C an additive agent.

Keywords: Ascorbic Acid - therapeutic use, Carnitine - therapeutic use, Antioxidants - therapeutic use, Ascorbic Acid - therapeutic use, Burns - drug therapy, Carnitine - therapeutic use, Skin - pathology, Surgical Flaps

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750